Breast cancer continues to be one of the most common cancers in North America and
Western Europe. Positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-d …

Background Whether PET scan maximum standard uptake value (SUVmax) could
differentiate luminal A from luminal B and help predict the survival of metastatic breast …

Purpose. Evidence from studies with small numbers of patients indicates that 18F‐
fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) …

Aim We aimed to compare the roles of 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in the
evaluation of primary tumor and metastases in primary and recurrent breast cancer …

Purpose The purpose of this pilot study was to assess whether outcome in metastatic or
recurrent breast cancer patients is related to metabolic response to endocrine therapy …

Our objective was to compare the predictive significance of 18F-FDG PET/CT findings and
circulating tumor cell (CTC) count in patients with bone metastases from breast cancer …

Scintimammography is a recently verified technique that will expand the use of nuclear
medicine to a new group of patients in whom scintigraphic imaging has not been widely …

Purpose To compare the diagnostic performance of 18-FDG-PET/MR and PET/CT for the N-
and M-staging of breast cancer. Methods and materials Two independent readers blinded to …

Abstract We have compared 2-deoxy-2-[18 F]-fluoro-d-glucose positron emission
tomography (FDG-PET) images of large or locally advanced breast cancers (LABC) …

Purpose To evaluate positron emission tomography (PET) using [18F] fluorodeoxyglucose
(FDG) for prediction of histopathologic response early during primary systemic therapy of …